name,cids,patents,descriptors
Semaglutide,56843331,"CA-3063324-A1,CA-3196937-A1,CN-102272136-B,CN-106478806-B,CA-2870488-A1,CN-104411710-A,AU-2022208128-B2,AU-2022208128-A1,CA-2771352-A1,CN-106478806-A","DPP-4 inhibitor,not mentioned,Antidiabetic agent,Not applicable"
Avexitide,"16198321,129012199,91976991","AU-2003268208-B2,AU-2003268208-A1,AU-2023251091-A1,AU-2005211755-B2,AU-2003201998-B2,AU-5552499-A,CA-3224859-A1,AU-2005211755-A1,AU-2019359807-A1,AU-2003201998-C1","inflammation inhibitor,CD200R antibody,immune modulator,not mentioned,Not applicable,Not enough information"
PP-F11N lutetium Lu-177,154572874,"CA-3231129-A1,AU-2021466987-A1,CN-118043482-A,CN-110891589-A,AU-2018280861-A1,EP-4188455-A1,CA-3210561-A1,AU-2021426543-A1,CA-3066240-C,CA-3066240-A1","Radiolabeled gastrin analogue,CCK2-R targeting,radiolabeled gastrin analogue,cancer treatment,radiopharmaceutical,CCK2R-targeting,cancer therapy"
Buserelin,"50225,50224","AU-1604899-A,AU-2006218733-A1,AU-2007243946-B2,AU-1227299-A,AU-2005249504-A1,AU-2007266521-B2,AU-2012203353-B2,AU-2000264796-A1,AT-500101-A1,AP-1195-A","Neuroprotective agent,Testosterone inhibitor"
Deslorelin,25077495,"AU-1053595-A,AU-1441301-A,AU-2001263039-B2,AU-2001269795-B2,AU-2001275423-B2,AU-1346601-A,AU-1843899-A,AU-2001261949-A1,AT-500101-A1,AP-1195-A","controlled release,Not applicable,transgenic animal production"
Nerofe,145722610,"CA-3196886-A1,CN-109069585-A,CA-2931023-C,CA-2931023-A1,AU-2017214850-A1,AU-2017214850-B2,CN-114203942-A,CN-116688096-A,CA-3013552-A1,CN-118987015-A","Anti-metastatic,Reduces cell motility,combination therapy,predictive tool,Neurodegenerative disease treatment,Memory enhancement,Cognitive function improvement,Cancer therapy,Anti-angiogenic"
